Friday, March 08, 2013 11:20:10 AM
I don't think anyone is shorting here, it is hedging for a profit, there are those big institutions that came in big in the 20s...and i don't want to speculate who that may be...they have been making a killing. ONE THING IS FOR SURE, THEY ARE NOT GREEDY! because approval of this drug will take this over the $1 threshold. b.o.l.t.y. my friend. this is of course if you can hold until decision time!
APPA is not looking preety right now, and BTIG is scaring any prospective investor right now... they are playing the mouse and the cat game...see if anyone else wanna play that game...I doubt. hedge fund is calling the shots now. IMOHO
APPA is not looking preety right now, and BTIG is scaring any prospective investor right now... they are playing the mouse and the cat game...see if anyone else wanna play that game...I doubt. hedge fund is calling the shots now. IMOHO
Recent HRTX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/13/2026 01:05:39 PM
- Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline • IH Market News • 05/11/2026 03:03:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 12:00:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 12:00:16 PM
- Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance • GlobeNewswire Inc. • 05/11/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 05:01:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 04:49:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 04:35:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 03:56:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 03:30:39 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 06:09:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 06:09:05 PM
- Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026 • GlobeNewswire Inc. • 04/27/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 03:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 01:41:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 01:13:37 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 09:13:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 11:06:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/06/2026 12:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:00:26 PM
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 07:40:59 PM
- Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026 • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
